A clinician examines a computer screen with an X-ray of bones.

ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in August.

September 6, 2023

ARUP Consult®, a free source of expert guidance in laboratory testing, has released new and updated resources on testing for osteoporosis, paraneoplastic pemphigus, and epilepsy.

These and other offerings, which summarize current clinical practice guidelines, testing strategies, and relevant technical details, are updated regularly and tailored to clinicians to help them choose the right test at the right time.

Read on for more information about these recent changes. Subscribe to the ARUP Consult monthly newsletter to have updates and highlights like these delivered directly to your inbox.

Osteoporosis - Bone Turnover Markers

model of bones

Although the screening and diagnosis of osteoporosis primarily rely on bone mineral density testing using imaging, laboratory testing plays a supportive role and may be useful in risk assessment and monitoring. The rewritten ARUP Consult Osteoporosis - Bone Turnover Markers topic describes when to consider laboratory testing, such as testing for markers of bone formation and resorption.

Immunobullous Diseases Testing - Neoplastic Disease


Paraneoplastic pemphigus is a severely debilitating autoimmune disease that usually involves an underlying neoplasm and presents with blistering of the skin and mucous membranes. The workup for this disease includes a clinical assessment, histopathology, and disease-specific autoantibody testing in tissue and serum. Refer to the updated Immunobullous Diseases Testing Algorithm - Neoplastic Disease for more details.

Comprehensive Epilepsy Panel

photo illustration of DNA strand

Genetics are estimated to contribute to approximately 30% of epilepsy cases. Genetic testing can be useful to identify the underlying cause of epilepsy and to inform prognosis, optimal treatment and management, risk of recurrence, and testing of at-risk relatives. Refer to the Comprehensive Epilepsy Panel, Sequencing and Deletion/Duplication Test Fact Sheet to learn about ARUP’s new genetic test.

Other Noteworthy Updates

Don’t forget to check out these other resources, now live on ARUP Consult:


Tickborne Diseases

Test Fact Sheets

Exome Sequencing
Thiopurine Metabolites in Red Blood Cells
Thiopurine Methyltransferase, RBC

Keeping Pace With What’s Next

blood cells

September is Blood Cancer Awareness Month, which makes it a good time to learn more about risk factors, symptoms, and testing strategies for leukemia, lymphoma, mast cell disorders, and other blood cancers. Refer to the Hematologic Malignancies topic for more information about how laboratory tests can be used in the diagnosis, prognosis, treatment, and management of these diseases.

Share Your Feedback

Use the Feedback button on each page at arupconsult.com or email us with any comments or questions.


Lisa Carricaburu, lisa.carricaburu@aruplab.com